乳腺增生会癌变吗,到底要不要治?每个女人都该知道

2017-09-18 霍莉莉 邱天 上海中医药大学附属上海市中西医结合医院治未病科 海上名医

近年来,一些女性名人因为乳腺癌英年早逝,使得很多人“谈乳色变”。当一些女性朋友在体检报告上发现“乳腺小叶增生”的字样时,不禁担心疑惑:乳腺小叶增生是怎么回事?我怎么会得这个毛病呢?这个病会不会发展成乳腺癌?需要治疗么?

近年来,一些女性名人因为乳腺癌英年早逝,使得很多人“谈乳色变”。当一些女性朋友在体检报告上发现“乳腺小叶增生”的字样时,不禁担心疑惑:乳腺小叶增生是怎么回事?我怎么会得这个毛病呢?这个病会不会发展成乳腺癌?需要治疗么?

乳腺增生是怎么回事?

乳腺增生分为生理性和病理性两种:

生理性增生

在体内多种激素的共同作用下,乳腺腺体出现周期性的增生和复旧,就像月经来潮,成为女性每个月都发生的正常生理现象。

病理性增生

在乳腺腺体增生和复旧的过程中,出现过度增生或复旧不全,引起乳腺结构的紊乱,成为病理性的增生,临床称为乳腺增生症,是常见的良性乳腺疾病。

其中,乳腺小叶增生是最常见的病理性增生类型。

乳腺增生症普遍么?

乳腺增生症是育龄期女性最常见的乳腺病,我国70%~80%的女性有不同程度的乳腺增生。据调查显示,2011年、2014年该病在育龄期妇女的检出率是分别为16.60%和22.41%,而2016年最新的报道显示检查率为32.69%。可见乳腺增生的发病呈逐年上升趋势。

乳腺增生症有哪些主要症状

乳房疼痛

乳腺结节或肿块

乳头溢液

情绪波动

月经失调

乳腺增生症与哪些因素有关呢?

内分泌失调:

主要是雌激素分泌过多,刺激乳腺过度增生而导致。

精神情绪因素:

长期工作压力大,人际关系不和,造成精神紧张,情绪易激动等负性情绪。

不良生活习惯:

熬夜睡眠不足,吸烟饮酒,内衣过紧,人工流产,女性高龄不育不哺乳等等。

饮食不节:

长期高糖、高脂饮食引起内分泌紊乱,诱发乳腺增生。

长期服用避孕药及含有雌激素的保健品。

乳腺增生如何治疗?

生理性增生:

单纯性的乳腺增生,不适症状较轻,随月经结束可自行消退者,一般无需特别处理。

因负面情绪或者不良生活方式引起的乳腺增生,可以通过控制情绪波动,改变不良生活饮食习惯等,促进乳腺增生消除。

病理性增生:

1.排除乳腺癌:及时到医院就诊,进行乳房彩超、钼靶等影像检查以及血肿瘤指标检测,对于可疑或不能排除恶性病变者,应配合医生进行穿刺、活检等进一步检查,必要时采取手术治疗,以免延误病情。

2.治疗乳腺增生症:如果排除乳腺癌,可在医生指导下,采用西药、中药内服或中医外治法治疗。

研究表明,乳腺增生症与乳腺癌并无必然关系,仅有极少数的患者会出现非典型性的增生改变,具有发展为乳腺癌的风险。尽管风险极低,但早期乳腺癌的临床表现并无特异性,容易被乳腺增生症所掩盖,故建议既往体检报告有乳腺增生症的女性朋友要定期到医院检查,帮助早期筛查乳腺癌。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=246479, encodeId=6a5f2464e969, content=学习了很多先进水平, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161027/IMG58114E1818EA51495.jpg, createdBy=4b2c1959822, createdName=雅文博武, createdTime=Fri Sep 22 06:32:07 CST 2017, time=2017-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1509122, encodeId=20c91509122ae, content=<a href='/topic/show?id=0ac123e0094' target=_blank style='color:#2F92EE;'>#乳腺增生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23700, encryptionId=0ac123e0094, topicName=乳腺增生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=359310047271, createdName=xre2011, createdTime=Wed Sep 20 05:05:00 CST 2017, time=2017-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557057, encodeId=f44c155e057ee, content=<a href='/topic/show?id=154be128170' target=_blank style='color:#2F92EE;'>#癌变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71281, encryptionId=154be128170, topicName=癌变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd7914850828, createdName=axin014, createdTime=Wed Sep 20 05:05:00 CST 2017, time=2017-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245408, encodeId=afcf245408c3, content=真的很棒!谢谢老师!, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/16/aa0b89194b7fdde13def13b62076d6e7.jpg, createdBy=427c2150570, createdName=ZYT20, createdTime=Mon Sep 18 19:41:28 CST 2017, time=2017-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245407, encodeId=ef9824540e73, content=真的很棒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/16/aa0b89194b7fdde13def13b62076d6e7.jpg, createdBy=427c2150570, createdName=ZYT20, createdTime=Mon Sep 18 19:41:17 CST 2017, time=2017-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245405, encodeId=4e0624540570, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Mon Sep 18 19:34:19 CST 2017, time=2017-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245361, encodeId=be3a24536123, content=越来越多的乳腺疾病, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/25/aee510ed68ce4736e9fe4ec7d03c01b1.jpg, createdBy=ce892064652, createdName=楠博One, createdTime=Mon Sep 18 16:48:07 CST 2017, time=2017-09-18, status=1, ipAttribution=)]
    2017-09-22 雅文博武

    学习了很多先进水平

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=246479, encodeId=6a5f2464e969, content=学习了很多先进水平, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161027/IMG58114E1818EA51495.jpg, createdBy=4b2c1959822, createdName=雅文博武, createdTime=Fri Sep 22 06:32:07 CST 2017, time=2017-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1509122, encodeId=20c91509122ae, content=<a href='/topic/show?id=0ac123e0094' target=_blank style='color:#2F92EE;'>#乳腺增生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23700, encryptionId=0ac123e0094, topicName=乳腺增生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=359310047271, createdName=xre2011, createdTime=Wed Sep 20 05:05:00 CST 2017, time=2017-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557057, encodeId=f44c155e057ee, content=<a href='/topic/show?id=154be128170' target=_blank style='color:#2F92EE;'>#癌变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71281, encryptionId=154be128170, topicName=癌变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd7914850828, createdName=axin014, createdTime=Wed Sep 20 05:05:00 CST 2017, time=2017-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245408, encodeId=afcf245408c3, content=真的很棒!谢谢老师!, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/16/aa0b89194b7fdde13def13b62076d6e7.jpg, createdBy=427c2150570, createdName=ZYT20, createdTime=Mon Sep 18 19:41:28 CST 2017, time=2017-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245407, encodeId=ef9824540e73, content=真的很棒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/16/aa0b89194b7fdde13def13b62076d6e7.jpg, createdBy=427c2150570, createdName=ZYT20, createdTime=Mon Sep 18 19:41:17 CST 2017, time=2017-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245405, encodeId=4e0624540570, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Mon Sep 18 19:34:19 CST 2017, time=2017-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245361, encodeId=be3a24536123, content=越来越多的乳腺疾病, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/25/aee510ed68ce4736e9fe4ec7d03c01b1.jpg, createdBy=ce892064652, createdName=楠博One, createdTime=Mon Sep 18 16:48:07 CST 2017, time=2017-09-18, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=246479, encodeId=6a5f2464e969, content=学习了很多先进水平, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161027/IMG58114E1818EA51495.jpg, createdBy=4b2c1959822, createdName=雅文博武, createdTime=Fri Sep 22 06:32:07 CST 2017, time=2017-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1509122, encodeId=20c91509122ae, content=<a href='/topic/show?id=0ac123e0094' target=_blank style='color:#2F92EE;'>#乳腺增生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23700, encryptionId=0ac123e0094, topicName=乳腺增生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=359310047271, createdName=xre2011, createdTime=Wed Sep 20 05:05:00 CST 2017, time=2017-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557057, encodeId=f44c155e057ee, content=<a href='/topic/show?id=154be128170' target=_blank style='color:#2F92EE;'>#癌变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71281, encryptionId=154be128170, topicName=癌变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd7914850828, createdName=axin014, createdTime=Wed Sep 20 05:05:00 CST 2017, time=2017-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245408, encodeId=afcf245408c3, content=真的很棒!谢谢老师!, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/16/aa0b89194b7fdde13def13b62076d6e7.jpg, createdBy=427c2150570, createdName=ZYT20, createdTime=Mon Sep 18 19:41:28 CST 2017, time=2017-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245407, encodeId=ef9824540e73, content=真的很棒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/16/aa0b89194b7fdde13def13b62076d6e7.jpg, createdBy=427c2150570, createdName=ZYT20, createdTime=Mon Sep 18 19:41:17 CST 2017, time=2017-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245405, encodeId=4e0624540570, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Mon Sep 18 19:34:19 CST 2017, time=2017-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245361, encodeId=be3a24536123, content=越来越多的乳腺疾病, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/25/aee510ed68ce4736e9fe4ec7d03c01b1.jpg, createdBy=ce892064652, createdName=楠博One, createdTime=Mon Sep 18 16:48:07 CST 2017, time=2017-09-18, status=1, ipAttribution=)]
    2017-09-20 axin014
  4. [GetPortalCommentsPageByObjectIdResponse(id=246479, encodeId=6a5f2464e969, content=学习了很多先进水平, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161027/IMG58114E1818EA51495.jpg, createdBy=4b2c1959822, createdName=雅文博武, createdTime=Fri Sep 22 06:32:07 CST 2017, time=2017-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1509122, encodeId=20c91509122ae, content=<a href='/topic/show?id=0ac123e0094' target=_blank style='color:#2F92EE;'>#乳腺增生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23700, encryptionId=0ac123e0094, topicName=乳腺增生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=359310047271, createdName=xre2011, createdTime=Wed Sep 20 05:05:00 CST 2017, time=2017-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557057, encodeId=f44c155e057ee, content=<a href='/topic/show?id=154be128170' target=_blank style='color:#2F92EE;'>#癌变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71281, encryptionId=154be128170, topicName=癌变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd7914850828, createdName=axin014, createdTime=Wed Sep 20 05:05:00 CST 2017, time=2017-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245408, encodeId=afcf245408c3, content=真的很棒!谢谢老师!, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/16/aa0b89194b7fdde13def13b62076d6e7.jpg, createdBy=427c2150570, createdName=ZYT20, createdTime=Mon Sep 18 19:41:28 CST 2017, time=2017-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245407, encodeId=ef9824540e73, content=真的很棒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/16/aa0b89194b7fdde13def13b62076d6e7.jpg, createdBy=427c2150570, createdName=ZYT20, createdTime=Mon Sep 18 19:41:17 CST 2017, time=2017-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245405, encodeId=4e0624540570, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Mon Sep 18 19:34:19 CST 2017, time=2017-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245361, encodeId=be3a24536123, content=越来越多的乳腺疾病, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/25/aee510ed68ce4736e9fe4ec7d03c01b1.jpg, createdBy=ce892064652, createdName=楠博One, createdTime=Mon Sep 18 16:48:07 CST 2017, time=2017-09-18, status=1, ipAttribution=)]
    2017-09-18 ZYT20

    真的很棒!谢谢老师!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=246479, encodeId=6a5f2464e969, content=学习了很多先进水平, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161027/IMG58114E1818EA51495.jpg, createdBy=4b2c1959822, createdName=雅文博武, createdTime=Fri Sep 22 06:32:07 CST 2017, time=2017-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1509122, encodeId=20c91509122ae, content=<a href='/topic/show?id=0ac123e0094' target=_blank style='color:#2F92EE;'>#乳腺增生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23700, encryptionId=0ac123e0094, topicName=乳腺增生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=359310047271, createdName=xre2011, createdTime=Wed Sep 20 05:05:00 CST 2017, time=2017-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557057, encodeId=f44c155e057ee, content=<a href='/topic/show?id=154be128170' target=_blank style='color:#2F92EE;'>#癌变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71281, encryptionId=154be128170, topicName=癌变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd7914850828, createdName=axin014, createdTime=Wed Sep 20 05:05:00 CST 2017, time=2017-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245408, encodeId=afcf245408c3, content=真的很棒!谢谢老师!, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/16/aa0b89194b7fdde13def13b62076d6e7.jpg, createdBy=427c2150570, createdName=ZYT20, createdTime=Mon Sep 18 19:41:28 CST 2017, time=2017-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245407, encodeId=ef9824540e73, content=真的很棒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/16/aa0b89194b7fdde13def13b62076d6e7.jpg, createdBy=427c2150570, createdName=ZYT20, createdTime=Mon Sep 18 19:41:17 CST 2017, time=2017-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245405, encodeId=4e0624540570, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Mon Sep 18 19:34:19 CST 2017, time=2017-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245361, encodeId=be3a24536123, content=越来越多的乳腺疾病, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/25/aee510ed68ce4736e9fe4ec7d03c01b1.jpg, createdBy=ce892064652, createdName=楠博One, createdTime=Mon Sep 18 16:48:07 CST 2017, time=2017-09-18, status=1, ipAttribution=)]
    2017-09-18 ZYT20

    真的很棒!

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=246479, encodeId=6a5f2464e969, content=学习了很多先进水平, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161027/IMG58114E1818EA51495.jpg, createdBy=4b2c1959822, createdName=雅文博武, createdTime=Fri Sep 22 06:32:07 CST 2017, time=2017-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1509122, encodeId=20c91509122ae, content=<a href='/topic/show?id=0ac123e0094' target=_blank style='color:#2F92EE;'>#乳腺增生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23700, encryptionId=0ac123e0094, topicName=乳腺增生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=359310047271, createdName=xre2011, createdTime=Wed Sep 20 05:05:00 CST 2017, time=2017-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557057, encodeId=f44c155e057ee, content=<a href='/topic/show?id=154be128170' target=_blank style='color:#2F92EE;'>#癌变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71281, encryptionId=154be128170, topicName=癌变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd7914850828, createdName=axin014, createdTime=Wed Sep 20 05:05:00 CST 2017, time=2017-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245408, encodeId=afcf245408c3, content=真的很棒!谢谢老师!, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/16/aa0b89194b7fdde13def13b62076d6e7.jpg, createdBy=427c2150570, createdName=ZYT20, createdTime=Mon Sep 18 19:41:28 CST 2017, time=2017-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245407, encodeId=ef9824540e73, content=真的很棒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/16/aa0b89194b7fdde13def13b62076d6e7.jpg, createdBy=427c2150570, createdName=ZYT20, createdTime=Mon Sep 18 19:41:17 CST 2017, time=2017-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245405, encodeId=4e0624540570, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Mon Sep 18 19:34:19 CST 2017, time=2017-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245361, encodeId=be3a24536123, content=越来越多的乳腺疾病, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/25/aee510ed68ce4736e9fe4ec7d03c01b1.jpg, createdBy=ce892064652, createdName=楠博One, createdTime=Mon Sep 18 16:48:07 CST 2017, time=2017-09-18, status=1, ipAttribution=)]
    2017-09-18 清风拂面

    谢谢分享.学习了

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=246479, encodeId=6a5f2464e969, content=学习了很多先进水平, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161027/IMG58114E1818EA51495.jpg, createdBy=4b2c1959822, createdName=雅文博武, createdTime=Fri Sep 22 06:32:07 CST 2017, time=2017-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1509122, encodeId=20c91509122ae, content=<a href='/topic/show?id=0ac123e0094' target=_blank style='color:#2F92EE;'>#乳腺增生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23700, encryptionId=0ac123e0094, topicName=乳腺增生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=359310047271, createdName=xre2011, createdTime=Wed Sep 20 05:05:00 CST 2017, time=2017-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557057, encodeId=f44c155e057ee, content=<a href='/topic/show?id=154be128170' target=_blank style='color:#2F92EE;'>#癌变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71281, encryptionId=154be128170, topicName=癌变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd7914850828, createdName=axin014, createdTime=Wed Sep 20 05:05:00 CST 2017, time=2017-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245408, encodeId=afcf245408c3, content=真的很棒!谢谢老师!, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/16/aa0b89194b7fdde13def13b62076d6e7.jpg, createdBy=427c2150570, createdName=ZYT20, createdTime=Mon Sep 18 19:41:28 CST 2017, time=2017-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245407, encodeId=ef9824540e73, content=真的很棒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/16/aa0b89194b7fdde13def13b62076d6e7.jpg, createdBy=427c2150570, createdName=ZYT20, createdTime=Mon Sep 18 19:41:17 CST 2017, time=2017-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245405, encodeId=4e0624540570, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Mon Sep 18 19:34:19 CST 2017, time=2017-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245361, encodeId=be3a24536123, content=越来越多的乳腺疾病, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/25/aee510ed68ce4736e9fe4ec7d03c01b1.jpg, createdBy=ce892064652, createdName=楠博One, createdTime=Mon Sep 18 16:48:07 CST 2017, time=2017-09-18, status=1, ipAttribution=)]
    2017-09-18 楠博One

    越来越多的乳腺疾病

    0

相关资讯

港中大研发出人工智能技术诊断肺癌及乳腺癌

香港中文大学6日宣布,该校研究团队利用人工智能影像识别技术判读肺癌及乳腺癌的医学影像,准确率分别达91%及99%,识别过程只需30秒至10分钟。研究人员称,此项技术可大幅提升临床诊断效率,并降低误诊率。

J Bone Miner Res:纤维发育不良增加乳腺癌的风险

乳腺癌是女性中最常见的癌症之一,威胁着全世界女性的生命,关于乳腺癌风险因素的研究比比皆是,最近,发表于《骨骼与矿物质》杂志上的一项研究指出,纤维发育不良(FD)会增加患乳腺癌的风险。

CLIN CANCER RES:HER2+乳腺癌HER2靶向治疗耐药机制

HER2+乳腺癌抗HER2治疗可能通过其他通路活化或HER信号通路再激活导致耐药。CLIN CANCER RES近期发表了一篇文章,使用BT474亲代和治疗抵抗细胞系模型研究在HER2靶向治疗时HER2+乳腺癌再激活HER网络的机制。

Genetics:研究发现使乳腺癌女性恢复生育能力的关键点!

根据一项新的研究,现有的药物有一天可以保护绝经前妇女免受生殖改变致不孕的影响,这种不育症常常伴随癌症治疗。

晚期乳腺癌内分泌治疗药物纳入国家医保

继今年《国家基本医疗保险、工伤保险和生育保险药品目录》第4次调整,以及人社部公布国家医保药品谈判准入结果后,9月起,北京、天津、浙江、安徽、江苏、湖北、吉林、河南等多个省市将落实2017年版国家药品目录。此次医保乙类目录中新增36种药品,约半数为肿瘤用药,涉及乳腺癌、肺癌、胃癌等常见癌种。

CA Cancer J Clin:肥胖与乳腺癌的发病风险及预后:机制及干预措施

近几十年来,肥胖症的发病率迅猛上升,肥胖对健康的影响也日益明显。2014年全世界约有19亿多成年人超重(体重指数[BMI],25-29.9 kg/m2),其中6亿多人为肥胖者(BMI ≥30 kg/m2)。众所周知,肥胖可增加糖尿病和冠状动脉疾病的发病风险,但是肥胖对癌症的发生、发病率和死亡率的影响却并没有得到充分的重视。肥胖可增加女性乳腺癌的发病风险,特别是绝经后妇女,还可恶化所有年龄段女性的疾